Steady as she goes. Unfortunately current sentiment just not there for emerging biotech. Money in the bank, no debt, decent pipeline and revenues increasing. A lot to like but it’s a slow train. GLTA
Ann: Quarterly Activity Report & Appendix 4C, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $148.2M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 61.0¢ | $305.9K | 499.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 40558 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 11.23am 01/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |